Previous Article | Next Article ![]()
Journal of Clinical Microbiology, October 2003, p. 4793-4795, Vol. 41, No. 10
0095-1137/03/$08.00+0 DOI: 10.1128/JCM.41.10.4793-4795.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong SAR, China
Received 10 February 2003/ Returned for modification 19 May 2003/ Accepted 14 July 2003
Seventy-three chronic hepatitis B patients who had either hepatitis B e antigen (HBeAg) seroconversion (group I) or HBeAg-negative disease (group II) were studied. HBV DNA levels at HBeAg seroconversion (group I) and at initial visits (group II) were significantly lower among patients who were persistently negative for HBeAg than among those who underwent HBeAg reversion.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»